» Articles » PMID: 36297583

Chitosan As a Functional Carrier for the Local Delivery Anti-Inflammatory Systems Containing Extract

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Oct 27
PMID 36297583
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to establish the influence of chitosan on the preparation of systems containing extract and to demonstrate the potential of anti-inflammatory action for the treatment of periodontitis. In the first stage, the impact of the variables (extraction mixture composition, temperature, and the number of extraction cycles) on the extracted samples' biological characteristics was analyzed using the Design of Experiments (DoE) approach. The best conditions for baicalin, baicalein, and wogonin extraction from were 80% methanol in the extraction mixture, 70 °C, and 4 cycles per 60 min. The DoE approach can be used to choose the best chitosan system parameters with equal success. An increase in the deacetylation degree of chitosan used in the system improved the potential for reducing free radicals and inhibiting the hyaluronidase enzyme. Also, increasing the degree of chitosan deacetylation results in increased resistance of the carrier to biodegradation and an extended baicalin release profile, which is also associated with an increase in the viscosity of the chitosan-based system. In total, the system of a freeze-dried extract with chitosan 90/500 in the ratio of 2:1 (system S9) turns out to be the one with the best physicochemical (high percentage of baicalin release and the highest viscosity conditioning the prolonged stay at the site of administration) and biological properties (the highest antioxidant and anti-inflammatory activities), resulting in the highest potential for use in the treatment of oral inflammatory diseases.

Citing Articles

A Commentary on "Chitosan, a Natural Polymer, is an Excellent Sustained-Release Carrier for Amide Local Anesthetics" [Letter].

Wu Y, Fang J, Jian Y J Pain Res. 2024; 17:3801-3802.

PMID: 39568462 PMC: 11577929. DOI: 10.2147/JPR.S504807.


Implementing the Design of Experiments (DoE) Concept into the Development of Mucoadhesive Tablets Containing Orange Peel Extract as a Potential Concept for the Treatment of Oral Infections.

Paczkowska-Walendowska M, Karpinski T, Garbiec E, Walendowski M, Cielecka-Piontek J Materials (Basel). 2024; 17(21).

PMID: 39517510 PMC: 11547214. DOI: 10.3390/ma17215234.


Chitosan, a Natural Polymer, is an Excellent Sustained-Release Carrier for Amide Local Anesthetics.

Yu Y, Long Y, Zhu Z J Pain Res. 2024; 17:3539-3551.

PMID: 39493932 PMC: 11531737. DOI: 10.2147/JPR.S480926.


Electrospun Nanofibers with Pomegranate Peel Extract as a New Concept for Treating Oral Infections.

Paczkowska-Walendowska M, Ignacyk M, Miklaszewski A, Plech T, Karpinski T, Kwiatek J Materials (Basel). 2024; 17(11).

PMID: 38893822 PMC: 11173823. DOI: 10.3390/ma17112558.


Chitosan/Pomegranate Seed Oil Emulgel Composition as a New Strategy for Dermal Delivery of Hydrocortisone.

Baginska Z, Paczkowska-Walendowska M, Basa A, Rachalewski M, Lendzion K, Cielecka-Piontek J Int J Mol Sci. 2024; 25(7).

PMID: 38612575 PMC: 11012218. DOI: 10.3390/ijms25073765.


References
1.
Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe S . Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 2014; 94(2):329-54. PMC: 4044300. DOI: 10.1152/physrev.00040.2012. View

2.
Sip S, Paczkowska-Walendowska M, Rosiak N, Miklaszewski A, Grabanska-Martynska K, Samarzewska K . Chitosan as Valuable Excipient for Oral and Topical Carvedilol Delivery Systems. Pharmaceuticals (Basel). 2021; 14(8). PMC: 8401298. DOI: 10.3390/ph14080712. View

3.
Shahid N, Erum A, Zaman M, Tulain U, Shoaib Q, Malik N . Synthesis and evaluation of chitosan based controlled release nanoparticles for the delivery of ticagrelor. Des Monomers Polym. 2022; 25(1):55-63. PMC: 8942484. DOI: 10.1080/15685551.2022.2054117. View

4.
Prabaharan M, Mano J . Chitosan-based particles as controlled drug delivery systems. Drug Deliv. 2005; 12(1):41-57. DOI: 10.1080/10717540590889781. View

5.
Mujtaba M, Khawar K, Camara M, Carvalho L, Fraceto L, Morsi R . Chitosan-based delivery systems for plants: A brief overview of recent advances and future directions. Int J Biol Macromol. 2020; 154:683-697. DOI: 10.1016/j.ijbiomac.2020.03.128. View